LAUREN E KULIK

Allopathic & Osteopathic Physicians|Internal Medicine WYANDOTTE, MI NPI 1205181583

General Payments — all program years on this page

$3,238.86

  • Category: General Payments
  • Program years: PY2018–2021
  • Record count: 236
  • As of (CMS publication): 2026-01-23

Latest program year (PY2021): $353.46 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2021) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $353.4621

By paying entity

Latest program year (PY2021) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $996.1677
2019 $1,216.5392
2020 $672.7146
2021 $353.4621

Records — PY2021 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
763605422 Boehringer Ingelheim Pharmaceuticals, Inc. $17.28 01/12/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
787984219 Janssen Pharmaceuticals, Inc $16.88 05/03/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
787984221 Janssen Pharmaceuticals, Inc $11.73 02/17/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
787984223 Janssen Pharmaceuticals, Inc $19.70 06/07/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
792532345 Currax Pharmaceuticals LLC $13.58 02/18/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
795174701 AbbVie Inc. $16.61 01/21/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
795174707 AbbVie Inc. $13.59 03/29/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
795174711 AbbVie Inc. $25.04 03/30/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
795174715 AbbVie Inc. $17.45 05/19/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
801837761 GlaxoSmithKline, LLC. $24.87 05/13/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
803202711 GlaxoSmithKline, LLC. $16.23 02/12/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
810954833 Novo Nordisk Inc $23.30 02/08/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
810993359 Novo Nordisk Inc $20.50 05/04/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
811071685 Novo Nordisk Inc $15.41 04/12/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
820030815 Takeda Pharmaceuticals U.S.A., Inc. $16.30 04/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
820917957 Nestle HealthCare Nutrition Inc. $18.07 04/01/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833526585 PFIZER INC. $12.90 04/08/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
837539777 Corcept Therapeutics $14.21 05/11/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
839640785 Teva Pharmaceuticals USA, Inc. $15.44 03/16/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
845575103 JAZZ PHARMACEUTICALS INC. $12.03 01/06/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
845582561 JAZZ PHARMACEUTICALS INC. $12.34 04/28/2021 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.